Stock Track | Sino Biopharm Soars 5.07% on Massive Insider Purchase by Founder

Stock Track

Aug 29

Sino Biopharmaceutical Limited (HKG:1177) saw its stock price soar by 5.07% during Friday's intraday trading session, catching investors' attention amidst a significant insider purchase.

The surge in stock price comes on the heels of a substantial insider transaction. Ping Tse, the Founder and Senior Executive Vice Chairman of Sino Biopharmaceutical, invested a whopping HK$222 million to acquire company shares at an average price of HK$7.44. This purchase, while only increasing Tse's holding by 1.8%, represents a strong vote of confidence in the company's future prospects.

Insider buying often signals management's belief in the company's value and potential for growth. This substantial investment by a key executive could be interpreted as a positive indicator for Sino Biopharm's outlook. The company already boasts high insider ownership at 51%, suggesting strong alignment between management and shareholder interests. As the market digests this information, investors appear to be responding favorably, driving up the stock price in today's trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1151712727"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151712727\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151712727?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-29 11:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151712727","market":"nz","top_or_hot":-1,"title":"Stock Track | Sino Biopharm Soars 5.07% on Massive Insider Purchase by Founder","media":"Stock Track","content":"<p>Sino Biopharmaceutical Limited (HKG:1177) saw its stock price soar by 5.07% during Friday's intraday trading session, catching investors' attention amidst a significant insider purchase.</p>\n\n<p>The surge in stock price comes on the heels of a substantial insider transaction. Ping Tse, the Founder and Senior Executive Vice Chairman of Sino Biopharmaceutical, invested a whopping HK$222 million to acquire company shares at an average price of HK$7.44. This purchase, while only increasing Tse's holding by 1.8%, represents a strong vote of confidence in the company's future prospects.</p>\n\n<p>Insider buying often signals management's belief in the company's value and potential for growth. This substantial investment by a key executive could be interpreted as a positive indicator for Sino Biopharm's outlook. The company already boasts high insider ownership at 51%, suggesting strong alignment between management and shareholder interests. As the market digests this information, investors appear to be responding favorably, driving up the stock price in today's trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Sino Biopharm Soars 5.07% on Massive Insider Purchase by Founder</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Sino Biopharm Soars 5.07% on Massive Insider Purchase by Founder\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-29 11:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sino Biopharmaceutical Limited (HKG:1177) saw its stock price soar by 5.07% during Friday's intraday trading session, catching investors' attention amidst a significant insider purchase.</p>\n\n<p>The surge in stock price comes on the heels of a substantial insider transaction. Ping Tse, the Founder and Senior Executive Vice Chairman of Sino Biopharmaceutical, invested a whopping HK$222 million to acquire company shares at an average price of HK$7.44. This purchase, while only increasing Tse's holding by 1.8%, represents a strong vote of confidence in the company's future prospects.</p>\n\n<p>Insider buying often signals management's belief in the company's value and potential for growth. This substantial investment by a key executive could be interpreted as a positive indicator for Sino Biopharm's outlook. The company already boasts high insider ownership at 51%, suggesting strong alignment between management and shareholder interests. As the market digests this information, investors appear to be responding favorably, driving up the stock price in today's trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01177","symbol_name":"中国生物制药","start_time":0,"source_url":"","article_id":"1151712727","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151712727","pubTimestamp":1756436593,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Sino Biopharmaceutical Limited (HKG:1177) saw its stock price soar by 5.07% during Friday's intraday trading session, catching investors' attention amidst a significant insider purchase.  The surge...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01177":"中国生物制药"},"translate_title":"个股赛道|中国生物制药大涨5.07%受创始人大规模内幕收购影响","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01177":1},"content_text":"Sino Biopharmaceutical Limited (HKG:1177) saw its stock price soar by 5.07% during Friday's intraday trading session, catching investors' attention amidst a significant insider purchase.\nThe surge in stock price comes on the heels of a substantial insider transaction. Ping Tse, the Founder and Senior Executive Vice Chairman of Sino Biopharmaceutical, invested a whopping HK$222 million to acquire company shares at an average price of HK$7.44. This purchase, while only increasing Tse's holding by 1.8%, represents a strong vote of confidence in the company's future prospects.\nInsider buying often signals management's belief in the company's value and potential for growth. This substantial investment by a key executive could be interpreted as a positive indicator for Sino Biopharm's outlook. The company already boasts high insider ownership at 51%, suggesting strong alignment between management and shareholder interests. As the market digests this information, investors appear to be responding favorably, driving up the stock price in today's trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}